1 Jul 2021 17:01
Ap24
AMENDMENT
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 24 June 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
919,623 | 10.4600 GBP | 10.3200 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
1,234,370 | 10.4600 GBP | 10.3258 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a short position | 5,000 10,070 2,090 1,296 6,105
206,267 2,177 40 270,000 11,120 5,040 839 420 2,221 7,308
13 481
542 7,220 16,822 396 395 584 4,536 2,635 3,620 100,000 1,454 655 250 2,109 4,756 3,170 442 1,168
70,000 | 10.3521 GBP 10.3932 GBP 10.4003 GBP 10.4020 GBP 10.4125 GBP
10.3478 GBP 10.3824 GBP 10.4000 GBP 10.4020 GBP 10.4032 GBP 10.4194 GBP 10.4275 GBP 10.4400 GBP 10.4462 GBP 10.4595 GBP
10.3992 GBP 10.4598 GBP
10.3304 GBP 10.3385 GBP 10.3530 GBP 10.3551 GBP 10.3554 GBP 10.3563 GBP 10.3564 GBP 10.3570 GBP 10.3584 GBP 10.3604 GBP 10.3640 GBP 10.3789 GBP 10.3808 GBP 10.3935 GBP 10.4004 GBP 10.4156 GBP 10.4501 GBP 10.4600 GBP
10.3509 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Date of disclosure | 01 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |